Combining biomarkers to detect disease with application to prostate cancer
Combining biomarkers to detect disease with application to prostate cancer
In early detection of disease, combinations of biomarkers promise improved discrimination over diagnostic tests based on single markers. An example of this is in prostate cancer screening, where additional markers have been sought to improve the specificity of the conventional ProstateāSpecific Antigen (PSA) test. A marker of particular interest is ā¦